Revenue from operations during the latest December quarter declined to Rs 720 crore from Rs 826 crore in the same quarter last year. The full year revenues declined 5.5 per cent to Rs 2,901 crore compared with Rs 3,070 crore during the last year.
The company, however, said that financial results for the quarter ended December 31, 2020 are not comparable with that of corresponding quarter in 2019 due to completion of slump sale transaction on May 29, 2020, which resulted in transfer of Ankleshwar manufacturing facility and few products to Zentiva Private Limited.
"Sales performance for the year ended December 31, 2020 has been negatively impacted due to Covid-19 pandemic. The impact assessment of Covid-19 pandemic is a continuing process given the uncertainties associated with its nature and duration," Sanofi India
said in a filing.
"The board recommended the payment of a final dividend of Rs 125 per equity share of Rs 10 each for the year ended 31 December 2020 and a special dividend of Rs. 240 per equity share of Rs 10 each for the year ended 31 st December 2020, after considering the closure of the slump sale transaction relating to Ankleshwar Manufacturing facility and reviewing the cash requirements for the Company's operations," the company said in a filing.
"Closure of register of members and share transfer books from April 21 to April 27 (both days inclusive) for determining the eligibility of shareholders for payment of the final dividend and the special dividend," it said.
The company will hold Annual General Meeting (AGM) on April 27, 2021 through video conferencing and further details of the AGM will be provided in the due course.
The company also announced the re-appointment of Aditya Narayan as an independent director and chairman.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.